In the context of radiotherapy, one could hypothesize that DNMT inhibitors might radiosensitize tumor cells by reactivating pro-apoptotic pathways or by preventing the methylation-dependent silencing of DNA damage response genes. The gene discussed is DNMT1; the disease is neoplasm.